Parallel Advisors, LLC Praxis Precision Medicines, Inc. Transaction History

Parallel Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$2.5 - $37.95 $925 - $14,041	370 New	370 $1,000
Q1 2022 Apr 28, 2022	SELL	$10.21 - $20.29 $765 - $1,521	-75 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$16.76 - $22.99 $1,525 - $2,092	-91 Reduced 54.82%	75 $1,000
Q3 2021 Nov 02, 2021	BUY	$13.15 - $22.56 $1,564 - $2,684	119 Added 253.19%	166 $3,000
Q2 2021 Aug 06, 2021	BUY	$18.28 - $33.05 $859 - $1,553	47 New	47 $1,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.